Clinical Trials Logo
  1. Home
  2. Traumatic Hemorrhage
  3. NCT03780894

Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage at Pre-hospital Phase of Care. — PRETIC  

Polytrauma Clinical Trial

Official title:
Transfusion of Red Blood Cells (RBC), Tranexamic Acid (TXA) and Fibrinogen Concentrate (FC) for Severe Trauma Hemorrhage at Pre-hospital Phase of Care. A Pilot Trial.

Clinical Trial Summary

This is a single-center, not-randomized, open-label, controlled pilot clinical trial. This study compares presence of Trauma Induced Coagulopathy (TIC) and acute traumatic hemorrhage treatment at pre-hospital phase of care with red blood cells (RBC), Tranexamic acid (TXA) and Fibrinogen Concentrate (FC) with the current treatment based on the administration of Crystalloids and TXA.

Clinical Trial Description

A pilot, non-randomized, open-label study of two intervention arms and controlled with the standard treatment in which 60 patients affected with acute hemorrhage due to severe trauma will enter the study with the main objective of evaluating the feasibility and the efficacy of early treatment during the pre-hospital care phase with packed red blood cells, fibrinogen concentrate and tranexamic acid (experimental arm) compared to the standard treatment based on crystalloids administration and tranexamic acid (control arm). The secondary objectives are to evaluate the safety and clinical evolution of the patients. Prior to the administration of the treatment, 2 blood samples will be extracted in both groups in order to compare the coagulation status and to be able to perform the pre-transfusion tests. On arrival at the hospital, another sample will be taken to compare changes in coagulation after the administration of the experimental or standard treatment and also between both groups. The assessment of the coagulation status will be made using the values provided by the viscoelastic test (TEG6s). The experimental and standard treatment will be administered endovenously. After treatment, patients will be evaluated up to 30 days. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03780894
Study type Interventional
Source Banc de Sang i Teixits
Contact
Status Completed
Phase Phase 1/Phase 2
Start date November 21, 2018
Completion date January 11, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT03730688 - Non-invasive Limb Compartment Pressure Measurement N/A
Not yet recruiting NCT05544773 - Comparing Trauma Severity Scores Injury Severity Score "ISS", Rapid Emergency Medicine Score "REMS" and Kampala Trauma Score "KTS"
Completed NCT04107818 - Comparison of Viscoelastic Measurement by ROTEM® Delta and ClotPro® in Trauma Patients.
Completed NCT01193686 - Peer Visitation for OEF/OIF Veterans N/A
Active, not recruiting NCT03098459 - Illuminating Neuropsychological Dysfunction and Systemic Inflammatory Mechanisms Gleaned After Hospitalization in Trauma-ICU Study
Completed NCT03588767 - Endocrine Response of the Organism to Polytrauma N/A
Suspended NCT00555126 - Forced Air Versus Endovascular Warming in Polytrauma Patients Phase 4
Not yet recruiting NCT04766944 - Incidence and Associated Risk Factors of ARC in the Trauma Critically Ill Older Than 50 Years Old
Recruiting NCT05794256 - Genderspecific Differences in Hormone Levels After Trauma
Suspended NCT03066817 - Vitamin D and Bone Homeostasis in Ortho Polytrauma Patients Phase 1/Phase 2
Completed NCT04410952 - Pelvic Binder vs. Pelvic C-clamp for Bleeding Control
Recruiting NCT06351826 - Effectiveness of ELLASI Intervention Towards Polytrauma Patients in the Emergency Department N/A
Not yet recruiting NCT05954936 - Trauma Registry in Villavicencio, Colombia
Completed NCT05221476 - Red Blood Cell Distribution Width and Charlson Comorbidity Indeces in the Frail Polytraumatized Patient.
Completed NCT04335838 - Age, Traumatic Brain Injury and Injury Severity as Independent Risk Factors for In-Hospital Mortality in Polytrauma Patients.
Completed NCT04723992 - 25-Year Experience With Polytraumatized Patients in a Level 1 Trauma Center
Recruiting NCT06305819 - Effectiveness of a Self-management Program After Traumatic Injury N/A
Active, not recruiting NCT06312436 - The AT-REBOA Target Trial
Active, not recruiting NCT03218280 - Oxidative Stress Expression and Metabolic Imbalance in Critically Ill Polytrauma Patients and the Implications of Antioxidant Therapy on Clinical Outcomes N/A
Completed NCT05074095 - Analysis of Urogenital Injuries in Polytraumatized Patients